Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter Prognosis Determined by BRCA Mutation and Family History in Ovarian Cancer

Liu Weiling; Wang Zhizhong; Ma JieHou YangyangZhao JiuzhouDong BingTu ShichunWang LiGuo Yongjun

首页> 外文期刊>Genetic testing and molecular biomarkers >Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter Prognosis Determined by BRCA Mutation and Family History in Ovarian Cancer

【24h】

Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter Prognosis Determined by BRCA Mutation and Family History in Ovarian Cancer

机译：升高血清CA125水平是一个生物标志物可以用来改变预后取决于BRCA吗突变,在卵巢癌家族史

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: In this study, we determined whether serum tumor markers (STMs), including CA125, are associated with BRCA mutation status and if they can be used prognostically in sporadic ovarian cancer (SOC) and familial ovarian cancer (FOC).

机译：目的:在这项研究中,我们确定血清肿瘤标记物(STMs),包括CA125如果他们与BRCA突变状态可以使用在零星的卵巢影响预后吗癌症(SOC)和家族性卵巢癌(FOC)。

著录项

来源
《Genetic testing and molecular biomarkers》 |2017年第9期|547-554|共8页
作者
Liu Weiling; Wang Zhizhong; Ma JieHou YangyangZhao JiuzhouDong BingTu ShichunWang LiGuo Yongjun;
展开▼
作者单位

Scintillon Inst Biomed & Bioenergy Res, San Diego, CA USA;

Zhengzhou Univ, Affiliated Canc Hosp, Dept Oncol Surg, Zhengzhou, Henan, Peoples R China;

Zhengzhou Univ, Affiliated Canc Hosp, Dept Obstet & Gynecol, Zhengzhou 450003, Henan, Peoples R ChinaZhengzhou Univ, Affiliated Canc Hosp, Dept Mol Pathol, Zhengzhou 450003, Henan, Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
Serum levels; CA-125 Antigen; Ovary CancerBiological MarkersGenealogical TreePrognosis;

机译：血清ca - 125抗原;子房CancerBiological;

相似文献

外文文献
中文文献

Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter Prognosis Determined by BRCA Mutation and Family History in Ovarian Cancer

摘要

著录项

相似文献

相关主题

期刊订阅